<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02808065</url>
  </required_header>
  <id_info>
    <org_study_id>17-2016-001-5</org_study_id>
    <nct_id>NCT02808065</nct_id>
  </id_info>
  <brief_title>Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients</brief_title>
  <official_title>Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Food and Drug Safety, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <brief_summary>
    <textblock>
      Pharmacokinetic model to predict interaction between tacrolimus and mycophenolate was
      developed through clinical trial with healthy volunteer. The purpose of this study is to
      confirm predictability of developed pharmacokinetic model in kidney transplant recipients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study participants take their immunosuppressant as usual. One day, blood is drawn at predose
      and 1, 2, 3, 4-hour postdose to compare observed concentration with model-predicted
      concentration of tacrolimus and mycophenolate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tacrolimus concentration</measure>
    <time_frame>0, 1, 2, 3, 4 hours post-dose</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mycophenolate concentration</measure>
    <time_frame>0, 1, 2, 3, 4 hours post-dose</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>Tacrolimus + Mycophenolate mofetil</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tacrolimus</intervention_name>
    <description>Administered dose were individualized according to their own prescription</description>
    <arm_group_label>Tacrolimus + Mycophenolate mofetil</arm_group_label>
    <other_name>Prograf</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Mycophenolate mofetil</intervention_name>
    <description>Administered dose were individualized according to their own prescription</description>
    <arm_group_label>Tacrolimus + Mycophenolate mofetil</arm_group_label>
    <other_name>Cellcept</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        40 kidney transplant recipients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18 years or older

          -  At least 6 months after kidney transplantation

          -  Were on tacrolimus alone or tacrolimus plus mycophenolate based immunosuppressive
             regimen

          -  Maintained stable dose of immunosuppressants for at least two weeks

        Exclusion Criteria:

          -  AST or ALT &gt;3 upper limit of normal range

          -  Had gastrointestinal disorder that may affect an absorption of drug

          -  Coadministration of drugs that may affect the pharmacokinetics of immunosuppressive
             drug

          -  Multi-organ transplant recipient

          -  Severe psychiatric disorder

          -  Drug or alcohol abuser

          -  Pregnant

          -  Low compliance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yon Su Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jae Hyun Kim</last_name>
    <phone>82-2-2072-0335</phone>
    <email>jaerung90@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae Hyun Kim</last_name>
      <phone>82-2-2072-0335</phone>
      <email>jaerung90@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 17, 2016</study_first_submitted>
  <study_first_submitted_qc>June 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2016</study_first_posted>
  <last_update_submitted>June 17, 2016</last_update_submitted>
  <last_update_submitted_qc>June 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yon Su Kim</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Kidney transplant</keyword>
  <keyword>Kidney transplantation</keyword>
  <keyword>Renal transplant</keyword>
  <keyword>Renal transplantation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
    <mesh_term>Mycophenolic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

